ARPHA OAI-PMH Endpoint
metadata only
CC BY 4.0
Pamrevlumab inhibits posterior capsule opacification via selective CTGF/β-catenin axis modulation and collagen-1 suppression in primary pediatric LECs
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Assess Safety, Efficacy, and Pharmacokinetics of INM004 in Pediatric Patients With STEC-HUS#217147
- Navigating the Spectrum of Cariology: Laser-Mediated Theranostics in Pediatric and Adult Populations.#621061
- Phase 3 Alogliptin Pediatric Study#126088
- 21 U.S.C. § 393a — Office of Pediatric Therapeutics#577188
- SEC 8-K — MATEON THERAPEUTICS INC (OTLC) (0001493152-19-013911) · filed 2019-09-10#608686
Record · ID 383295
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive